Oral antiviral therapies are cost-effective vs. no treatment but indirect comparisons should be avoided.
Lorenzo G
LG
Mantovani
Simona
S
de Portu
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000191:economics*; D003362:Cost-Benefit Analysis; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D018803:Models, Economic
D000998:Antiviral Agents